208 related articles for article (PubMed ID: 38100711)
1. Moving into the modern era of molecular classification for endometrial cancer.
Dagher C; Liu YL; Mueller JJ; Weigelt B
J Surg Oncol; 2024 Jan; 129(1):120-125. PubMed ID: 38100711
[TBL] [Abstract][Full Text] [Related]
2. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
3. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma.
Travaglino A; Raffone A; Mollo A; Borrelli G; Alfano P; Zannoni GF; Insabato L; Zullo F
Arch Gynecol Obstet; 2020 May; 301(5):1117-1125. PubMed ID: 32253551
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases.
Korczynski J; Jesionek-Kupnicka D; Gottwald L; Piekarski J
Int J Gynecol Pathol; 2011 Jul; 30(4):328-34. PubMed ID: 21623209
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer from early to advanced-stage disease: an update for radiologists.
Luna C; Balcacer P; Castillo P; Huang M; Alessandrino F
Abdom Radiol (NY); 2021 Nov; 46(11):5325-5336. PubMed ID: 34297164
[TBL] [Abstract][Full Text] [Related]
6. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort.
Koskas M; Chabbert-Buffet N; Bendifallah S; Luton D; Clavel-Chapelon F; Rouzier R
Int J Gynecol Cancer; 2012 Mar; 22(3):447-51. PubMed ID: 22367322
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
10. High risk endometrial cancer: Clues towards a revision of the therapeutic paradigm.
Bendifallah S; Ilenko A; Daraï E
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):863-871. PubMed ID: 31176047
[TBL] [Abstract][Full Text] [Related]
11. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
12. It is time to implement molecular classification in endometrial cancer.
Bruno V; Logoteta A; Chiofalo B; Mancini E; Betti M; Fabrizi L; Piccione E; Vizza E
Arch Gynecol Obstet; 2024 Mar; 309(3):745-753. PubMed ID: 37410149
[TBL] [Abstract][Full Text] [Related]
13. Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer.
Kobayashi-Kato M; Fujii E; Asami Y; Ahiko Y; Hiranuma K; Terao Y; Matsumoto K; Ishikawa M; Kohno T; Kato T; Shiraishi K; Yoshida H
Gynecol Oncol; 2023 Nov; 178():36-43. PubMed ID: 37748269
[TBL] [Abstract][Full Text] [Related]
14. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
15. [Application and clinical significance of TCGA molecular classification in endometrial cancer].
Zhao LY; Dai YB; Li LW; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):697-704. PubMed ID: 34823319
[No Abstract] [Full Text] [Related]
16. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of FIGO 2009 staging I and its prognostic related factors in endometrial carcinoma].
Zhou J; Zhao L; Qi W; Li X; Wang J; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):776-9. PubMed ID: 25537252
[TBL] [Abstract][Full Text] [Related]
18. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
[TBL] [Abstract][Full Text] [Related]
19. Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer.
Eriksson LSE; Nastic D; Lindqvist PG; Imboden S; Järnbert-Pettersson H; Carlson JW; Epstein E
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):457-468. PubMed ID: 33314410
[TBL] [Abstract][Full Text] [Related]
20. FIGO staging system for endometrial cancer: added benefits of MR imaging.
Beddy P; O'Neill AC; Yamamoto AK; Addley HC; Reinhold C; Sala E
Radiographics; 2012; 32(1):241-54. PubMed ID: 22236905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
